Position in BCYC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,097,163
-$3,732,128 QoQ
Shares Held
1,529,561
0.0% QoQ
Ownership
2.19%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCYC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GSK plc holds $589,621,639 across 12 Biotechnology names. BCYC ranks #10 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
3,220,627 | $153,205,226 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
18,245,691 | $132,281,259 | |
| 3 | BNTX |
BioNTech SE
|
889,824 | $79,087,557 | |
| 4 | VIR |
Vir Biotechnology, Inc.
|
8,550,954 | $76,616,547 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
|
1,333,333 | $44,426,655 | |
| 6 | LYEL |
Lyell Immunopharma, Inc.
|
1,512,659 | $30,343,939 | |
| 7 | CYTK |
Cytokinetics Inc
|
340,434 | $22,438,004 | |
| 8 | SPRO |
Spero Therapeutics, Inc.
|
9,190,606 | $21,506,018 |
All Filings in BCYC
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,097,163 | 1,529,561 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,829,291 | 1,529,561 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||